Insider · CIK 0001882909
Sandra Calvin
officer
Files at TVTX (Travere Therapeutics, Inc.). First filing Nov 25, 2024, latest Sep 17, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 10
$0 bought, $5.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TVTX: Travere Therapeutics, Inc.
TVTXOct 9, 2026 · close 52.13
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Travere Therapeutics, Inc. | $335k 5,375 shares | -11% | +175% from low-7% from high | |
| 41Moderate | Travere Therapeutics, Inc. | $139k 4,333 shares | -8% | +143% from low-18% from high | |
| 29Weak | Travere Therapeutics, Inc. | $296k 7,402 shares | -16% | +199% from low0% from high | |
| 20Weak | Travere Therapeutics, Inc. | $105k 2,910 shares | -6% | +158% from low-5% from high | |
| 40Moderate | Travere Therapeutics, Inc. | $2.4M 67,115 shares | -58% | +153% from low-3% from high | |
| 40Moderate | Travere Therapeutics, Inc. | $1.4M 54,244 shares | -74% | - | |
| 38Weak | Travere Therapeutics, Inc. | $67k 3,348 shares | -5% | - | |
| 30Weak | Travere Therapeutics, Inc. | $18k 925 shares | -2% | - | |
| 6Weak | Travere Therapeutics, Inc. | $258k 15,000 shares | -21% | - | |
| 17Weak | TVTXsell Travere Therapeutics, Inc. | $221k 12,090 shares | -18% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,500 | $27.50 | $69k | 44,853 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +1,250 | $22.40 | $28k | 46,103 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +1,625 | $20.46 | $33k | 47,728 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,275 | $62.14 | $266k | 43,453 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -800 | $62.85 | $50k | 42,653 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -300 | $63.66 | $19k | 42,353 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 0 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -1,250 | $0.00 | $0 | 3,750 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -1,625 | $0.00 | $0 | 17,875 | 25 d ago |
| Jan 31, 2026 | TVTX Travere Therapeutics, Inc. | AGrant or award Common Stock | +15,180 | $0.00 | $0 | 53,413 | Feb 3, 2026 |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock | -4,333 | $32.12 | $139k | 49,080 | Feb 3, 2026 |
| Jan 31, 2026 | TVTX Travere Therapeutics, Inc. | AGrant or award Employee stock option (right to buy)derivative | +20,160 | $0.00 | $0 | 20,160 | Feb 3, 2026 |
| Dec 24, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -7,402 | $40.00 | $296k | 38,233 | Dec 29, 2025 |
| Dec 15, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,910 | $36.00 | $105k | 45,635 | Dec 16, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $25.25 | $253k | 64,410 | Nov 6, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +17,500 | $26.88 | $470k | 81,910 | Nov 6, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +15,000 | $27.50 | $413k | 96,910 | Nov 6, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +12,500 | $22.40 | $280k | 109,410 | Nov 6, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,250 | $8.93 | $56k | 115,660 | Nov 6, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -67,115 | $36.00 | $2.4M | 48,545 | Nov 6, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 0 | Nov 6, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -17,500 | $0.00 | $0 | 0 | Nov 6, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 2,500 | Nov 6, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -12,500 | $0.00 | $0 | 7,500 | Nov 6, 2025 |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -6,250 | $0.00 | $0 | 18,750 | Nov 6, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $16.23 | $162k | 73,654 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $25.00 | $250k | 63,654 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $17.44 | $174k | 73,654 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $25.00 | $250k | 63,654 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $17.96 | $180k | 73,654 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $25.00 | $250k | 63,654 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +15,000 | $15.46 | $232k | 78,654 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $25.00 | $375k | 63,654 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -9,244 | $25.00 | $231k | 54,410 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Jan 31, 2025 | TVTX Travere Therapeutics, Inc. | AGrant or award Common Stock | +13,000 | $0.00 | $0 | 67,002 | Feb 4, 2025 |
| Feb 3, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock | -3,348 | $20.12 | $67k | 63,654 | Feb 4, 2025 |
| Jan 31, 2025 | TVTX Travere Therapeutics, Inc. | AGrant or award Employee stock option (right to buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Feb 4, 2025 |
| Jan 22, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock | -925 | $18.94 | $18k | 54,002 | Jan 23, 2025 |
| Dec 26, 2024 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +15,000 | $12.67 | $190k | 69,927 | Dec 27, 2024 |
| Dec 26, 2024 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $17.22 | $258k | 54,927 | Dec 27, 2024 |
| Dec 26, 2024 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 0 | Dec 27, 2024 |
| Nov 25, 2024 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock | +15,000 | $12.67 | $190k | 67,017 | Nov 25, 2024 |
| Nov 25, 2024 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock | -12,090 | $18.30 | $221k | 54,927 | Nov 25, 2024 |
| Nov 25, 2024 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative | -15,000 | $0.00 | $0 | 15,000 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.